Page last updated: 2024-12-07
thoron (reagent)
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
thoron (reagent): indicator for microtitration of sulfate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
aspan: a silicocarboxyl dental cement [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 77270 |
SCHEMBL ID | 8649094 |
MeSH ID | M0059693 |
PubMed CID | 77269 |
SCHEMBL ID | 416050 |
SCHEMBL ID | 4950631 |
MeSH ID | M0059693 |
Synonyms (56)
Synonym |
---|
thoron (reagent) |
2,7-naphthalenedisulfonic acid, 4-[(2-arsonophenyl)azo]-3-hydroxy- |
132-33-2 |
unii-622f4knw84 |
4-((2-arsonophenyl)azo)-3-hydroxy-2,7-naphthalenedisulfonic acid |
4-((2-arsonophenyl)azo)-3-hydroxynaphthalene-2,7-disulphonic acid |
2,7-naphthalenedisulfonic acid, 4-(2-(2-arsonophenyl)diazenyl)-3-hydroxy- |
2,7-naphthalenedisulfonic acid, 4-((2-arsonophenyl)azo)-3-hydroxy- |
einecs 205-058-2 |
622f4knw84 , |
DTXSID9059624 |
SCHEMBL8649094 |
thorin sodium |
4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid |
2,7-naphthalenedisulfonic acid, 4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy- |
(4z)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxo-naphthalene-2,7-disulfonic acid |
4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy-2,7-naphthalenedisulfonic acid |
benzenearsonic acid, o-(2-hydroxy-3,6-disulfo-1-naphthylazo)- |
arans |
1-[(2-arsonophenyl)azo]-2-hydroxy-3,6-naphthalenedisulfonic acid |
thorin free acid |
naphtharson |
disodium 4-((o-arsonophenyl)azo)-3-hydroxynaphthalene-2,7-disulphonate |
nsc 148365 |
unii-lfp7cnk4m5 |
4-((2-arsonophenyl)azo)-3-hydroxy-2,7-naphthalenedisulfonic acid, disodium salt |
lfp7cnk4m5 , |
einecs 222-993-1 |
thoron |
nsc-148365 |
3688-92-4 |
thorin |
thorin 1 |
H0240 |
1-(2-arsonophenylazo)-2-naphthol-3,6-disulfonic acid disodium salt |
disodium 1-(2-arsonophenylazo)-2-naphthol-3,6-disulfonate |
aspan |
2-(2-hydroxy-3,6-disulfo-1-naphthylazo)benzenearsonic acid disodium salt |
disodium (4e)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxonaphthalene-2,7-disulfonate |
disodium (4e)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxidanylidene-naphthalene-2,7-disulfonate |
A823442 |
AKOS015903215 |
thoronol |
SCHEMBL416050 |
SCHEMBL4950631 |
J-610046 |
mfcd00003888 |
thorin i |
DTXSID20893911 |
Q416786 |
sodium (e)-4-((2-arsonophenyl)diazenyl)-3-hydroxynaphthalene-2,7-disulfonate |
disodium;4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate |
2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol hydrochoride[( inverted exclamation marka)tolterodine hydrochoride] |
2,7-naphthalenedisulfonic acid, 4-((2-arsonophenyl)azo)-3-hydroxy-, disodium salt |
2,7-naphthalenedisulfonic acid, 4-((o-arsonophenyl)azo)-3-hydroxy-, disodium salt |
2,7-naphthalenedisulfonic acid, 4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy-, sodium salt (1:2) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (12)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 6 (50.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Trials | 1 (14.29%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |